The A.I. Daily
AI Tool Tumor Site Risk Wins FDA Clearance
The FDA has cleared Tumor Site Risk, an AI tool that analyzes existing breast MRI scans to estimate a patient's risk of cancer returning five or ten years after diagnosis. With nearly 400,000 US women diagnosed with breast cancer annually, it helps patients better understand recurrence likelihood.